FDA Brief

Warning letters Drugs

FDA warning letter to

Fagron Group B.V.

Issued Jun 14, 2022Posted Jun 28, 2022Division of Pharmaceutical Quality Operations III

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.